![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Soterix Medical Wins CE Mark for Depression Therapy System
Soterix Medical Wins CE Mark for Depression Therapy System
![](https://www.fdanews.com/ext/resources/test/Device_Images5/SoterixMedical_Logo.png?t=1453338399&width=430)
Soterix Medical has snapped up the CE Mark for its 1x1 tDCS therapy system for the treatment of major depressive disorder.
The noninvasive, nonsystemic therapeutic device delivers low-intensity direct current to a region of the cerebral cortex in the brain, which is responsible for controlling mood.
According to the New York, N.Y.-based company, the system does not have the side effects commonly associated with oral antidepressant medications. — Michael Cipriano
Upcoming Events
-
11Jul
-
18Jul
-
21Oct